{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:49:31Z","timestamp":1787698171623,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:p>Rhabdomyolysis can occur due to many traumatic and nontraumatic causes. Rhabdomyolysis has been reported in new type of coronavirus disease (COVID-19) cases. The aim of our study was to examine the effects of rhabdomyolysis on mortality and renal outcomes in patients hospitalized in our hospital\u2019s COVID-19 wards. In our single-center and retrospective study, we included patients who were admitted with a diagnosis of COVID-19 by a thorax-computed tomography finding who were older than 18 years of age and with a measured creatinine kinase (CK)\u2005&gt;\u20051000 U\/L on any day of hospitalization. The same number of patients hospitalized in COVID-19 services with CK\u2005&lt;\u20051000 U\/L and with similar gender and age were determined as the control group. We analyzed the data of 2065 patients, and compared 154 patients in the rhabdomyolysis group (group 1) and 154 patients in the control group (group 2). Acute kidney injury (AKI) (44.2% vs 21.4%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), intensive care unit (ICU) admissions (53.2% vs 13.6%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), intubation (75.6% vs 23.8%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), mortality (36.4% vs 3.2%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) and the need for dialysis (3.9% vs 0.6%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.005) were seen more in the rhabdomyolysis group. When that group was divided into the early rhabdomyolysis group (group 1a), where the CK value reached its highest value in \u22643 days, and the late rhabdomyolysis group (group 1b), where it was\u2005\u2265\u20054 days, AKI (29.7% vs 65.1%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), ICU (35.2% vs 79.4%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), intubation (56.2% vs 88%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001), mortality (18% vs 61.9%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), and dialysis (1.1% vs 7.9%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.031), the results were higher in the group 1b. The available data suggest that rhabdomyolysis seen in COVID-19 patients is not a direct predictor of mortality and poor renal outcomes, but is a secondary outcome to multiple-organ failure caused by worsening clinical status.<\/jats:p>","DOI":"10.1097\/md.0000000000042368","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T22:24:15Z","timestamp":1746483855000},"page":"e42368","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Rhabdomyolysis in patients with COVID-19: A cause or consequence of acute kidney injury or mortality?"],"prefix":"10.1097","volume":"104","author":[{"given":"Yilmaz","family":"Mertsoy","sequence":"first","affiliation":[{"name":"Department of Orthopedics and Traumatology, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-7478","authenticated-orcid":false,"given":"Seyhmus","family":"Kavak","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Serdar","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Kacar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehmuz","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Traumatology, Van Yuzuncu Yil University, Dursun Odabas Medical Center, Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Gunay","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Health Sciences, Adana City Training and Research Hospital, Adana, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250513","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00005792-198205000-00002","article-title":"The spectrum of rhabdomyolysis.","volume":"61","author":"Gabow","year":"1982","journal-title":"Medicine (Baltim)"},{"key":"R2-20250513","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: rhabdomyolysis -- an overview for clinicians.","volume":"9","author":"Huerta-Alard\u00edn","year":"2005","journal-title":"Crit Care"},{"key":"R3-20250513","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","article-title":"Rhabdomyolysis: an evaluation of 475 hospitalized patients.","volume":"84","author":"Melli","year":"2005","journal-title":"Medicine (Baltim)"},{"key":"R4-20250513","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury.","volume":"361","author":"Bosch","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-20250513","first-page":"58","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment.","volume":"15","author":"Torres","year":"2015","journal-title":"Ochsner J"},{"key":"R6-20250513","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/CMR.00001-08","article-title":"Bacterial, fungal, parasitic, and viral myositis.","volume":"21","author":"Crum-Cianflone","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"R7-20250513","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1093\/rheumatology\/keaa351","article-title":"Rhabdomyolysis as the main manifestation of coronavirus disease 2019.","volume":"59","author":"Rivas-Garc\u00eda","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R8-20250513","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.radcr.2020.07.003","article-title":"Rhabdomyolysis as a manifestation of a severe case of COVID-19: a case report.","volume":"15","author":"Husain","year":"2020","journal-title":"Radiol Case Rep"},{"key":"R9-20250513","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3201\/eid2607.200445","article-title":"Rhabdomyolysis as potential late complication associated with COVID-19.","volume":"26","author":"Jin","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R10-20250513","first-page":"e7561","article-title":"Rhabdomyolysis as a presentation of 2019 novel Coronavirus disease.","volume":"12","author":"Suwanwongse","year":"2020","journal-title":"Cureus"},{"key":"R11-20250513","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.mayocp.2020.09.005","article-title":"Clinical characteristics, diagnosis, and outcomes of 6 patients with COVID-19 infection and rhabdomyolysis.","volume":"95","author":"Buckholz","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"R12-20250513","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMc2031085","article-title":"Covid-19-associated myopathy caused by type I interferonopathy.","volume":"383","author":"Manzano","year":"2020","journal-title":"N Engl J Med"},{"key":"R13-20250513","first-page":"177","article-title":"Severe rhabdomyolysis and acute renal failure following recent Coxsackie B virus infection.","volume":"61","author":"Fodili","year":"2003","journal-title":"Neth J Med"},{"key":"R14-20250513","first-page":"432","article-title":"Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease.","volume":"63","author":"Craighead","year":"1990","journal-title":"Lab Invest"},{"key":"R15-20250513","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mus.10053","article-title":"Rhabdomyolysis: a review.","volume":"25","author":"Warren","year":"2002","journal-title":"Muscle Nerve"},{"key":"R16-20250513","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejim.2006.09.020","article-title":"The syndrome of rhabdomyolysis: pathophysiology and diagnosis.","volume":"18","author":"Giannoglou","year":"2007","journal-title":"Eur J Intern Med"},{"key":"R17-20250513","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury.","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R18-20250513","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijid.2023.09.002","article-title":"COVID-19-associated rhbdomyolysis: a scoping review.","volume":"136","author":"Preger","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R19-20250513","first-page":"e37333","article-title":"Rhabdomyolysis in critically ill patientswith COVID-19: a restrospective study.","volume":"15","author":"Nashwan","year":"2023","journal-title":"Cureus"},{"key":"R20-20250513","doi-asserted-by":"crossref","first-page":"101015","DOI":"10.1016\/j.disamonth.2020.101015","article-title":"Rhabdomyolysis.","volume":"66","author":"Cabral","year":"2020","journal-title":"Dis Mon"},{"key":"R21-20250513","first-page":"61","article-title":"Rhabdomyolysis: revisited.","volume":"90","author":"Gupta","year":"2021","journal-title":"Ulster Med J"},{"key":"R22-20250513","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R23-20250513","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R24-20250513","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong.","volume":"348","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"R25-20250513","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/his.13379","article-title":"Histopathology of Middle East respiratory syndrome Coronovirus (MERSCoV) infection-clinicopathological and ultrastructural study.","volume":"72","author":"Alsaad","year":"2018","journal-title":"Histopathology"},{"key":"R26-20250513","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1038\/s41586-020-2951-z","article-title":"A pneumonia outbreak associated with a new Coronavirus of probable bat origin.","volume":"588","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"R27-20250513","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nmd.2014.05.005","article-title":"Rhabdomyolysis: review of the literature.","volume":"24","author":"Zutt","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"R28-20250513","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ndt\/9.6.637","article-title":"Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis.","volume":"9","author":"Veenstra","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"R29-20250513","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00134-003-1800-5","article-title":"Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey.","volume":"29","author":"de Meijer","year":"2003","journal-title":"Intensive Care Med"},{"key":"R30-20250513","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.ajkd.2005.11.019","article-title":"Epidemiologic aspects of the Bam earthquake in Iran: the nephrologic perspective.","volume":"47","author":"Hatamizadeh","year":"2006","journal-title":"Am J Kidney Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:05:38Z","timestamp":1747173938000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042368","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}